# US 2021/0333271 A1 · Methods for reducing noise in signal-generating digital assays

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0333271 A1
- Document ID: US20210333271A1
- Status: Published application
- Kind: A1
- Application number: 17/313,978
- Filed: 2021-05-06
- Published: 2021-10-28
- Earliest claimed: 2017-02-06
- Assignees: Abbott Japan Co., Ltd.
- Applicants: Abbott Japan LLC
- Inventors: Atsuko Futase
- Web page: https://patentgrep.com/patent/US20210333271A1

## CPC

- G01N 33/54373: {involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings}
- G01N 33/54306: {Solid-phase reaction mechanisms}
- G01N 33/54393: {Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Methods of reducing background noise in signal-generating digital assays, such as fluorescent digital immunoassays, using a colorant are disclosed. The methods utilize a binding member that specifically binds to an analyte in a biological sample. The binding member is conjugated to a signal generating compound, e.g., an enzyme, which is dissociated from the binding member. A colorant is added with a signal generating substrate, e.g., a fluorogenic or chromogenic substrate for the enzyme, or after a signal generating substrate to reduce background noise in a fluorescent digital immunoassay. The signal generated between the signal generating compound and the signal generating substrate is detected and correlated to the presence and/or concentration of the analyte.

## Claims

### Claim at position 1

-34. (canceled)

### Claim 35

A method for reducing fluorescence background noise in a signal-generating digital assay used to detect an analyte in a sample, the method comprising:
(a) contacting a fluid sample containing or suspected of containing the analyte with a plurality of solid supports to create a mixture, wherein each solid support comprises one or more first specific binding member capable of binding to the analyte thereby producing solid support-first specific binding member-analyte complexes;
(b) washing the solid support-first specific binding member-analyte complexes in the mixture with a first wash buffer to remove any solid support-first specific binding member not bound to the analyte thereby producing a washed mixture;
(c) adding to the washed mixture one or more second specific binding members capable of binding to the analyte thereby producing solid support-first specific binding member-analyte-second specific binding member complexes, wherein the second specific binding member comprises a signal generating compound attached thereto;
(d) washing the solid support-first specific binding member-analyte-second specific binding member complexes with a second wash buffer to remove any second specific binding member not bound to the analyte bound to the first specific binding member thereby producing washed solid support complexes;
(e) adding to the washed solid support complexes a signal generating substrate, wherein the signal generating compound and the signal generating substrate produce a detectable signal;
(f) spatially segregating at least a portion of the washed solid support complexes into a plurality of separate locations, wherein the plurality of separation locations comprises a plurality of reaction vessels and wherein the washed solid support complexes are present in an aqueous phase;
(g) covering the plurality of reaction vessels with a sealant, wherein the aqueous phase is displaced by the sealant in the reaction chamber; and
(h) detecting the presence or absence of the detectable signal using a digital counting device, wherein detection of the presence of the detectable signal indicates the presence of a single molecule of analyte in the sample,
wherein the digital counting device comprises a black device.

### Claim 36 (depends on 35)

The method of claim 35, wherein the signal-generating digital assay is a fluorescent digital immunoassay.

### Claim 37

A method for reducing fluorescence background noise in a fluorescent digital immunoassay used to detect an analyte in a sample, the method comprising:
(a) contacting a fluid sample containing or suspected of containing the analyte with a plurality of solid supports to create a mixture, wherein each solid support comprises one or more first specific binding member capable of binding to the analyte thereby producing solid support-first specific binding member-analyte complexes;
(b) washing the solid support-first specific binding member-analyte complexes in the mixture with a first wash buffer to remove any solid support-first specific binding member not bound to the analyte thereby producing a washed mixture;
(c) adding to the washed mixture one or more second specific binding members capable of binding to the analyte thereby producing solid support-first specific binding member-analyte-second specific binding member complexes, wherein the second specific binding member comprises a signal generating compound attached thereto;
(d) washing the solid support-first specific binding member-analyte-second specific binding member complexes with a second wash buffer to remove any second specific binding member not bound to the analyte bound to the first specific binding member thereby producing washed solid support complexes;
(e) adding to the washed solid support complexes a signal generating substrate, wherein the signal generating compound and the signal generating substrate produce a detectable signal;
(f) spatially segregating at least a portion of the washed solid support complexes into a plurality of separate locations, wherein the plurality of separation locations comprises a plurality of reaction vessels and wherein the washed solid support complexes are present in an aqueous phase;
(g) covering the plurality of reaction vessels with a sealant, wherein the aqueous phase is displaced by the sealant in the reaction chamber; and
(h) detecting the presence or absence of the detectable signal using a digital counting device, wherein detection of the presence of the detectable signal indicates the presence of a single molecule of analyte in the sample,
wherein the digital counting device comprises a black device.

### Claim 38 (depends on 35)

The method of claim 35, wherein the black device comprises a solid phase material comprising carbon black or a black film sheet attached to a transparent device.

### Claim 39 (depends on 38)

The method of claim 38, wherein the solid phase material is CYTOP, cyclic olefin polymers (COP), or polydimethylsiloxane (PDMS).

### Claim 40 (depends on 35)

The method of claim 35, further comprising adding a colorant to the washed solid support complexes simultaneously with the signal generating substrate, adding a colorant to the washed solid support complexes before the signal generating substrate, adding a colorant to the washed solid support complexes after the signal generating substrate, adding a colorant to the displaced aqueous phase, or adding a colorant to the sealant.

### Claim 41 (depends on 40)

The method of claim 40, wherein the colorant is a pigment-based composition.

### Claim 42 (depends on 40)

The method of claim 40, wherein the colorant is one of India Ink, Acid Black 2, Acid Orange 7, Direct Blue 14, or a combination thereof.

### Claim 43 (depends on 42)

The method of claim 42, wherein the colorant is a combination of Acid Orange 7 and Direct Blue 14.

### Claim 44 (depends on 35)

The method of claim 35, wherein the one or more second specific binding members are added simultaneously or sequentially to the one or more first specific binding members.

### Claim 45 (depends on 35)

The method of claim 35, wherein the signal generating compound is alkaline phosphatase or β-galactosidase.

### Claim 46 (depends on 35)

The method of claim 35, wherein the signal generating substrate is a fluorescent substrate for the signal generating compound.

### Claim 47 (depends on 35)

The method of claim 35, wherein the signal generating substrate is 4-methylumbelliferyl phosphate (MUP) or fluorescein diphosphate (FDP).

### Claim 48 (depends on 35)

The method of claim 35, wherein the detectable signal is detected using a fluorescence microscope to acquire fluorescence images.

### Claim 49 (depends on 35)

The method of claim 35, wherein the sealant has a density that is heavier than the aqueous phase.

### Claim 50 (depends on 35)

The method of claim 35, wherein the sealant is an oil.

### Claim 51 (depends on 50)

The method of claim 50, wherein the oil is a heavy fluorinated oil.

### Claim 52 (depends on 51)

The method of claim 51, wherein the heavy fluorinated oil is FC-40.

### Claim 53 (depends on 35)

The method of claim 35, wherein the plurality of reaction vessels is a nanowell array.

### Claim 54 (depends on 35)

The method of claim 35, further comprising in step (e) adding an inhibitor of signal generating compound.

### Claim 55 (depends on 54)

The method of claim 54, wherein the inhibitor is levamisole.

### Claim 56 (depends on 35)

The method of claim 35, further comprising incubating the mixture for a period of time before adding to the mixture one or more second specific binding members or after adding to the mixture one or more second specific binding members, wherein the period of time is an incubation period and is about 40 minute to about 300 minutes.

### Claim 57 (depends on 35)

The method of claim 35, wherein the fluid sample is serum, plasma or a whole blood sample.

### Claim 58 (depends on 35)

The method of claim 35, further comprising contacting the fluid sample with one or more detergents, a surfactant, a nonpolar solvent, sonication, heating, or combination thereof, prior to contacting the fluid sample to the plurality of solid supports.

### Claim 59 (depends on 35)

The method of claim 35, wherein the solid support is a magnetic solid support.

### Claim 60 (depends on 35)

The method of claim 35, wherein the aqueous phase is displaced by the sealant in step (g) by tilting the plurality of reaction vessels.

### Claim 61 (depends on 35)

The method of claim 35, wherein the analyte is a biological molecule.

### Claim 62 (depends on 61)

The method of claim 61, wherein the biological molecule is a protein, a peptide, a DNA molecule, a RNA molecule, a sugar, or a lipid.

### Claim 63 (depends on 35)

The method of claim 35, wherein the fluorescent digital immunoassay includes a femto-liter droplet array.
